Serial Number 86452336
Registration 5541252
702

Registration Progress

Application Filed
Nov 12, 2014
Under Examination
Jun 16, 2015
Approved for Publication
Apr 21, 2015
Published for Opposition
Apr 21, 2015
Registered
Aug 14, 2018

Basic Information

Serial Number
86452336
Registration Number
5541252
Filing Date
November 12, 2014
Registration Date
August 14, 2018
Published for Opposition
April 21, 2015
Drawing Code
2

Status Summary

Current Status
Active
Status Code
702
Status Date
Jan 9, 2025
Registration
Registered
Classes
005 042

Rights Holder

STEALTH BIOTHERAPEUTICS INC.

03
Address
Suite 201
123 Highland Ave
Needham, MA 02494

Ownership History

Stealth Peptides International Inc.

Original Applicant
03
MC98000 MC

Stealth Peptides International Inc.

Owner at Publication
03
MC98000 MC

STEALTH BIOTHERAPEUTICS CORP

New Owner After Publication #1
03
3-5 AVENUE DES CITRONNIERS MC

STEALTH BIOTHERAPEUTICS CORP

Original Registrant
03
3-5 AVENUE DES CITRONNIERS MC

STEALTH BIOTHERAPEUTICS INC.

New Owner After Registration #1
03
Needham, MA

Legal Representation

Attorney
Tricia L. Schulz

USPTO Deadlines

Next Deadline
1132 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-08-14)
Due Date
August 14, 2028
Grace Period Ends
February 14, 2029

Application History

48 events
Date Code Type Description
Jan 9, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 9, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 9, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 13, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED
Aug 14, 2023 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 3, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 3, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 3, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 3, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 3, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 8, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 14, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER
Jul 12, 2018 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 11, 2018 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 19, 2018 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Jun 15, 2018 IUAF S USE AMENDMENT FILED
Jun 15, 2018 EISU I TEAS STATEMENT OF USE RECEIVED
Dec 14, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 13, 2017 EX5G S SOU EXTENSION 5 GRANTED
Dec 11, 2017 EXT5 S SOU EXTENSION 5 FILED
Dec 11, 2017 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 15, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2017 EX4G S SOU EXTENSION 4 GRANTED
Jun 13, 2017 EXT4 S SOU EXTENSION 4 FILED
Jun 13, 2017 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 20, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 16, 2016 EX3G S SOU EXTENSION 3 GRANTED
Dec 16, 2016 EXT3 S SOU EXTENSION 3 FILED
Dec 16, 2016 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 23, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 22, 2016 EX2G S SOU EXTENSION 2 GRANTED
Jul 20, 2016 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 15, 2016 EXT2 S SOU EXTENSION 2 FILED
Jun 15, 2016 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 17, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 15, 2015 EX1G S SOU EXTENSION 1 GRANTED
Dec 15, 2015 EXT1 S SOU EXTENSION 1 FILED
Dec 15, 2015 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 26, 2015 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 16, 2015 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 21, 2015 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 21, 2015 PUBO A PUBLISHED FOR OPPOSITION
Apr 1, 2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 6, 2015 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 3, 2015 DOCK D ASSIGNED TO EXAMINER
Nov 20, 2014 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 19, 2014 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 15, 2014 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Biopharmaceutical preparations for the prevention and treatment of cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; biological preparations for the prevention and treatment of cellular abnormalities
First Use Anywhere: Apr 2, 2018
First Use in Commerce: Apr 2, 2018
Class 042
Scientific research and development; biopharmaceutical research, development and testing; medical and scientific research in the cardiovascular, renal, ophthalmic, neurologic and metabolic system fields
First Use Anywhere: Apr 2, 2018
First Use in Commerce: Apr 2, 2018

Additional Information

Design Mark
The mark consists of incomplete circular design with an opening at the top which has a vertical, notched bar or line design extending from near the center of the circular design upward through the opening.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 042